Finally, future studies of cerebral malaria, other severe malaria syndromes, and uncomplicated malaria that should include measurements of BK levels and activation of the kallikrein-kinin system before and after treatment with antimalarial drugs. This evidence concerns the gene KNG1 and malaria.